Clinical evaluation of systemic inflammatory response syndrome (SIRS) in advanced lung cancer (T3 and T4) with surgical resection

European Journal of Cardio-thoracic Surgery

Volumn 27, Issue 1, 2005, Pages 14-18

  Iwasaki, Akinori ^a   Shirakusa, Takayuki ^a   Maekawa, Takafumi ^a   Enatsu, Sotarou ^a   Maekawa, Shinichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Lung cancer; SIRS; Surgery

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ARTICLE; BRONCHUS FISTULA; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 11144285456     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.09.006     Document Type: Article

References (23)

1. D. Galetta, A. Cesario, S. Margaritora, V. Porziella, G. Macis, R.M. D'Angelillo, L. Trodella, S. Sterzi, and P. Granone Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach Ann Thorac Surg 76 2003 1802 1809
2. J. Martin, R.J. Ginsberg, E.S. Venkatraman, M.S. Bains, R.J. Downey, R.J. Korst, M.G. Kris, and V.W. Rusch Long-term results of combined-modality therapy in resectable non-small-cell lung cancer J Clin Oncol 20 2002 1989 1995
3. A.E. Martin-Ucar, R. Nicum, I. Oey, J.G. Edwards, and D.A. Waller En-bloc chest wall and lung resection for non-small cell lung cancer. Predictors of 60-day non-cancer related mortality Eur J Cardiothorac Surg 23 2003 859 864
4. E. Fadel, G. Missenard, A. Chapelier, S. Mussot, F. Leroy-Ladurie, J. Cerrina, and P. Dartevelle En bloc resection of non-small cell lung cancer invading the thoracic inlet and intervertebral foramina J Thorac Cardiovasc Surg 123 2002 676 685
5. L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, and G. Gotti Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy Eur J Cardiothorac Surg 20 2001 1106 1112
6. D.H. Grunenwald, F. Andre, C. Le Pechoux, P. Girard, C. Lamer, A. Laplanche, M. Tarayre, R. Arriagada, and T. Le Chevalier Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer J Thorac Cardiovasc Surg 122 2001 796 802
7. D.J. Muckart, and S. Bhagwanjee American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients Crit Care Med 25 1997 1789 1795
8. Y. Haga, T. Beppu, K. Doi, F. Nozawa, N. Mugita, S. Ikei, and M. Ogawa Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery Crit Care Med 25 1997 1994 2000
9. A. Sablotzki, I. Friedrich, J. Muhling, M.G. Dehne, J. Spillner, R.E. Silber, and E. Czeslik The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions Perfusion 17 2002 103 109
10. K. Hamano, T. Kawamura, H. Gohra, T. Katoh, Y. Fujimura, N. Zempo, M. Miyamoto, H. Tsuboi, Y. Tanimoto, and K. Esato Stress caused by minimally invasive cardiac surgery versus conventional cardiac surgery: incidence of systemic inflammatory response syndrome World J Surg 25 2001 117 121
11. B. Juhl, and N. Frost A comparison between measured and calculated changes in the lung functions after operation for pulmonary cancer Acta Anaesth Scand 57 1975 39 45
12. M. Kolsuz, S. Erginel, O. Alatas, F. Alatas, M. Metintas, I. Ucgun, E. Harmanci, and O. Colak Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia Respiration 70 2003 615 622
13. E.J. Oudijk, J.W. Lammers, and L. Koenderman Systemic inflammation in chronic obstructive pulmonary disease Eur Respir J Suppl 46 2003 5 13
14. G.D. Gass, and G.N. Olsen Preoperative pulmonary function testing to predict postoperative morbidity and mortality Chest 89 1986 127 135
15. M.H. Friedlander, R. Simon, and G.W. Machiedo The relationship of packed cell transfusion to red blood cell deformability in systemic inflammatory response syndrome patients Shock 9 1998 84 88
16. S. Ikuta, C. Miki, T. Hatada, Y. Inoue, T. Araki, K. Tanaka, H. Tonouchi, and M. Kusunoki Allogenic blood transfusion is an independent risk factor for infective complications after less invasive gastrointestinal surgery Am J Surg 185 2003 188 193
17. C.C. Silliman, L.K. Boshkov, Z. Mehdizadehkashi, D.J. Elzi, W.O. Dickey, L. Podlosky, G. Clarke, and D.R. Ambruso Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors Blood 101 2003 454 462
18. L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, and G. Gotti Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy Eur J Cardiothorac Surg 20 2001 1106 1112
19. G. Stamatis, D. Djuric, W. Eberhardt, C. Pottken, G. Zaboura, S. Fechner, and T. Fujimoto Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients Eur J Cardiothorac Surg 22 2002 292 297
20. B.D. Teague, F.G. Court, C.P. Morrison, M. Kho, S.A. Wemyss-Holden, and G.J. Maddern Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome Br J Surg 91 2004 178 183
21. T. Nozoe, T. Matsumata, and K. Sugimachi Significance of SIRS score in therapeutic strategy for acute appendicitis Hepatogastroenterology 49 2002 444 446
22. G.B. Johnson, G.J. Brunn, and J.L. Platt Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4 J Immunol. 172 2004 20 24
23. A. Matsushima, H. Ogura, T. Koh, K. Fujita, K. Yoshiya, Y. Sumi, H. Hosotsubo, Y. Kuwagata, H. Tanaka, T. Shimazu, and H. Sugimoto Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome J Trauma 56 2004 259 264